✦ LIBER ✦

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension

✍ Scribed by Raymond L. Benza; Werner Seeger; Vallerie V. McLaughlin; Richard N. Channick; Robert Voswinckel; Victor F. Tapson; Ivan M. Robbins; Horst Olschewski; Lewis J. Rubin

Book ID: 116523615
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 687 KB
Volume: 30
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2011.08.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

195 Safely Transitioning from Inhaled Il

195 Safely Transitioning from Inhaled Iloprost to Inhaled Treprostinil Sodium – Results from a Multicenter Open-Label Study in Patients with Pulmonary Arterial Hypertension

✍ R.C. Bourge; V.F. Tapson; Z. Safdar; R.L. Benza; R.N. Channick; E.B. Rosenzweig; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Effectiveness and Safety of Inhaled Trep

Effectiveness and Safety of Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Children

✍ Usha Krishnan; Shinichi Takatsuki; Dunbar D. Ivy; Jason Kerstein; Michelle Calde 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 560 KB

Baseline NT-proBNP correlates with chang

Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1

✍ Frantz, Robert P.; McDevitt, Susanne; Walker, Susan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Short-term drug interaction of bosentan

Short-term drug interaction of bosentan and sildenafil under the long-term use in patients with pulmonary arterial hypertension

✍ Miyakawa, Sachiko; Tanaka, Shimako; Goto, Takahiro; Uchida, Shinya; Takeuchi, Ka 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

The effect of open label UT15 or bosenta

The effect of open label UT15 or bosentan on hospitalisation days in patients with pulmonary arterial hypertension (PAH)

✍ A.M Keogh; K.M Brown; C.A Corrigan; C Allada; Y Ten 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 77 KB

EPITOME-2: An open-label study assessing

EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension

✍ Sitbon, Olivier; Delcroix, Marion; Bergot, Emmanuel; Boonstra, Anco B.; Granton, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 490 KB